Navigation Links
AAAS decries latest stem cell veto

The President has again vetoed the Stem Cell Research Enhancement Act, which would expand federal support for embryonic stem cell research. AAAS, the world’s largest general scientific society, stands with a broad coalition of Americans spanning all parties and faiths that supports this bill.

The scientific consensus is that embryonic stem cell research is an extremely promising approach to developing more effective treatments for devastating conditions like diabetes, spinal cord injuries, and Parkinson’s disease. The bill would mandate that such research be allowed to compete for federal funding while following strict ethical guidelines.

The Executive Order is not a substitute for the Stem Cell Research Enhancement Act. The new approaches addressed by the order are still in the early stages of development and appear to already be eligible for NIH funding. AAAS strongly believes that it is only through federal support of diverse avenues of stem cell research that we may better understand the potential value and limitations of each approach.

During his tenure the President has acknowledged that it is a critical time for the American scientific enterprise, therefore it is disappointing that he has chosen to maintain restrictions on such a promising area of research. AAAS will continue to support the interests of scientists and patients in fostering medical progress. The American Association for the Advancement of Science (AAAS) on Wednesday expressed disappointment with the decision by President George W. Bush to veto a landmark stem cell research funding bill.

The measure would have lifted restrictions on federal funding of medical research using embryonic stem cells, which proponents say would be derived from microscopic embryos left over and due to be discarded after in vitro fertility treatments. Current U.S. policy limits such funding to fewer than 20 stem cell lines that had been created when the president first announce d U.S. policy in 2001.

"Our concern is that this action has the potential to delay development of important new therapies by cutting off a promising avenue of research," said Alan I. Leshner, the chief executive officer of AAAS and executive publisher of the journal Science.

The president vetoed a similar bill that passed the Senate and House of Representatives last year. This year's measure won strong bi-partisan support in the U.S. House and Senate, but fell just short of the two-thirds supermajority needed to override the veto.

While Bush signed a separate Executive Order to support other stem cell research, AAAS "strongly believes" that all avenues of stem cell research must be explored, the non-partisan association said a statement.

The following is the full text of the AAAS statement:

"The President has again vetoed the Stem Cell Research Enhancement Act, which would expand federal support for embryonic stem cell research. AAAS, the world's largest general scientific society, stands with a broad coalition of Americans spanning all parties and faiths that supports this bill.

"The scientific consensus is that embryonic stem cell research is an extremely promising approach to developing more effective treatments for devastating conditions like diabetes, spinal cord injuries, and Parkinson's disease. The bill would mandate that such research be allowed to compete for federal funding while following strict ethical guidelines.

"The Executive Order is not a substitute for the Stem Cell Research Enhancement Act. The new approaches addressed by the order are still in the early stages of development and appear to already be eligible for NIH funding. AAAS strongly believes that it is only through federal support of diverse avenues of stem cell research, including especially embryonic stem cell research, that we may better understand the potential value and limitations of each approach.

"During his tenure the President has acknowledged that it is a critical time for the American scientific enterprise, therefore it is disappointing that he has chosen to maintain restrictions on such a promising area of research. AAAS will continue to support the interests of scientists and patients in fostering medical progress."


'"/>

Source:American Association for the Advancement of Science


Related biology news :

1. NHGRI announces latest sequencing targets

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/15/2016)... , Nov. 15, 2016  Synthetic Biologics, Inc. ... therapeutics focused on the gut microbiome, today announced ... 25,000,000 shares of its common stock and warrants ... at a price to the public of $1.00 ... Synthetic Biologics from the offering, excluding the proceeds, ...
(Date:6/22/2016)... June 22, 2016  The American College of Medical Genetics ... Executive Magazine as one of the fastest-growing trade shows ... at the Bellagio in Las Vegas . ... percentage of growth in each of the following categories: net ... and number of attendees. The 2015 ACMG Annual Meeting was ...
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
Breaking Biology News(10 mins):
(Date:12/6/2016)... 6, 2016 According to a new market ... (Polymer, Glass, Silicon), Application (Genomics, Proteomics, Capillary Electrophoresis, POC, Clinical, Environmental, ... global market is projected to reach USD 8.78 Billion by 2021 ... during the forecast period (2016 to 2021). ... ...
(Date:12/6/2016)... , Dec. 6, 2016  SRI International has ... million from the National Institutes of Health,s National ... Division of AIDS (NIAID-DAIDS) to support the manufacturing ... pre-exposure (PreP) agents. Under the seven-year contract, SRI ... development services for candidate HIV-prevention products that emerge ...
(Date:12/6/2016)... ... 2016 , ... RoviSys, a leading independent provider of comprehensive ... the opening of their new office building today. Located at 480 Green Oaks ... 200 employees focused on providing sales, engineering, and support services to customers in ...
(Date:12/5/2016)... Dec 5, 2016 Research and Markets ... - Technologies, Markets and Companies" to their offering. ... , , ... discovery using various -omics technologies such as proteomics and metabolomics. Molecular ... tests are also based on biomarker. Currently the most ...
Breaking Biology Technology: